Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 19:2:63.
doi: 10.3410/B2-63.

Pharmacogenetics of osteoporosis

Francesca Marini  1 , Maria Luisa Brandi
Affiliations

Pharmacogenetics of osteoporosis

Francesca Marini et al. F1000 Biol Rep. .

Abstract

Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouched. This review will provide an overview of the pharmacogenetics of osteoporosis, focusing on the major recent advances in the past two years.

PubMed Disclaimer

References

    1. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929–36. doi: 10.1016/S0140-6736(02)08761-5. - DOI - PubMed
    1. Nguyen TV, Eisman JA. Pharmacogenomics of osteoporosis: opportunities and challenges. J Musculoskelet Neuronal Interact. 2006;6:62–72. - PubMed
    1. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008;358:2355–65. doi: 10.1056/NEJMoa0801197. - DOI - PubMed

    2. F1000 Factor 8.0 Exceptional

      Evaluated by Peter Ebeling 16 Jun 2008, Robert Plenge 24 Jun 2008

    1. Jhonson JA, Evans WE. Molecular diagnostics as a predictive tool: genetics of drug efficacy and toxicity. Trends Mol Med. 2002;8:300–5. doi: 10.1016/S1471-4914(02)02354-7. - DOI - PubMed
    1. Weber WW. Effect of pharmacogenetics on medicine. Environ Mol Mutagen. 2001;37:179–184. doi: 10.1002/em.1026. - DOI - PubMed